Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3768 results

Sort By:

Latency Antibiotics for Previable Rupture Of Membranes Trial

Study ID: NCT06917157
Start Date: 2025-05-01
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

60

Intervention / Treatment

Administration of antibiotics prophylactically at the time of membrane rupture

Administration of antibiotics non-prophylactically at 22 weeks

Sponsor

The University of Texas Health Science Center, Houston

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Study ID: NCT06887348
Start Date: 2025-06
End Date: 2035-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Observational study with no interventions

Sponsor

Replimune Inc.

Source: clinicaltrials.gov

Share:
Add to list

Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery

Study ID: NCT01422148
Start Date: 2025-07
End Date: 2028-01-24
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Amiodarone

Minocycline

Sponsor

Baystate Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Vaccine Pandemic Preparedness Through Airway Immunology Characterization

Study ID: NCT05921448
Start Date: 2025-08-01
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

60

Intervention / Treatment

Vauxigripra

Flumist

Sponsor

Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Source: clinicaltrials.gov

Share:
Add to list

PARKINSON BRASIL - Database on Motor and Non-Motor Aspects of Parkinson's Disease in Brazil

Study ID: NCT06536348
Start Date: 2025-05-01
End Date: 2034-10-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

958

Intervention / Treatment
Sponsor

Federal University of Uberlandia

Source: clinicaltrials.gov

Share:
Add to list

Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma

Study ID: NCT05700448
Start Date: 2025-06
End Date: 2028-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

150

Intervention / Treatment

Sugemalimab

Placebo

Pegaspargase

Gemcitabine

Oxaliplatin

Sponsor

CStone Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

Study ID: NCT06902974
Start Date: 2025-08
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Psilocybin 25 mg

Sponsor

Sunstone Medical

Source: clinicaltrials.gov

Share:
Add to list

Resting-State Functional Connectivity As a Predictor of TDCS Effects in Adolescents with Autism Spectrum Disorder

Study ID: NCT06878326
Start Date: 2025-05
End Date: 2027-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

tDCS

Sponsor

The Hong Kong Polytechnic University

Source: clinicaltrials.gov

Share:
Add to list

AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function

Study ID: NCT05432765
Start Date: 2025-12
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

Phenotypic Personalized Medicine Dosing

Standard of Care Dosing

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

The PROTECT (PrEP Optimization Through Telehealth Care and Treatment) Trial

Study ID: NCT06845774
Start Date: 2025-05-15
End Date: 2026-11-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

CDC PrEP with active referral

Colon

Sponsor

Hilary L Surratt, PhD

Source: clinicaltrials.gov

Share:
Add to list